Search filters

List of works by Masashi Ando

21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patients.

scientific article published on 2 May 2009

A Phase II Study of Modified FOLFOX6 for Advanced Gastric Cancer Refractory to Standard Therapies

scientific article published on 07 May 2020

A multi-institutional phase II trial of paclitaxel and carboplatin in the treatment of advanced or recurrent cervical cancer

scientific article

A pilot feasibility study for cisplatin plus S-1 for the treatment for advanced or recurrent cervical cancer

scientific article

A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer.

scientific article published on 31 March 2010

Acute hyperammonemic encephalopathy after fluoropyrimidine-based chemotherapy: A case series and review of the literature

scientific article

An alternative medicine, Agaricus blazei, may have induced severe hepatic dysfunction in cancer patients

scientific article published on 14 November 2006

Analysis of the clinicopathological prognosis of stage IVb cervical carcinoma

scientific article published on 01 February 2008

Assessment of different criteria for the pathological complete response (pCR) to primary chemotherapy in breast cancer: standardization is needed

scientific article

Baseline Sarcopenia and Skeletal Muscle Loss During Chemotherapy Affect Survival Outcomes in Metastatic Gastric Cancer

scientific article published on 01 October 2018

Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer

scientific article

Cancer of unknown primary site: review of consecutive cases at the National Cancer Center Hospital of Japan

scientific article published on 25 December 2006

Clinical efficacy of S-1 in pretreated metastatic breast cancer patients

scientific article

Clinical outcomes of adult and childhood rhabdomyosarcoma treated with vincristine, d-actinomycin, and cyclophosphamide chemotherapy

scientific article published on 23 March 2012

Clinicopathological features of tumors as predictors of the efficacy of primary neoadjuvant chemotherapy for operable breast cancer

scientific article

Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome

scientific article published on 20 February 2008

Comparison of dose intensity of vincristine, d-actinomycin, and cyclophosphamide chemotherapy for child and adult rhabdomyosarcoma: a retrospective analysis.

scientific article published on 18 July 2012

Content analysis of oncology-related pharmaceutical advertising in a peer-reviewed medical journal

scientific article

Contrasting prognostic implications of platelet-derived growth factor receptor-β and vascular endothelial growth factor receptor-2 in patients with angiosarcoma.

scientific article

Correlation between human epidermal growth factor receptor 2 expression level and efficacy of trastuzumab beyond progression in metastatic gastric cancer ⬇️

scientific article published on 19 June 2017

Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast

scientific article published on 02 August 2006

Current state of therapeutic development for rare cancers in Japan, and proposals for improvement.

scientific article published in May 2018

Current trends and controversies over pre-operative chemotherapy for women with operable breast cancer

scientific article published on 3 January 2007

Depth of response predicts the clinical outcome of advanced HER2-positive gastric cancer to trastuzumab-based first-line chemotherapy

scientific article published on 18 August 2017

Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer

scientific article published on 05 June 2008

Diagnosis of complete response to neoadjuvant chemotherapy using diagnostic imaging in primary breast cancer patients.

scientific article published in September 2005

Efficacy of Cytotoxic Agents After Progression on Anti-PD-(L)1 Antibody for Pre-treated Metastatic Gastric Cancer

scientific article published on 01 April 2020

Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody

scientific article published on February 2017

Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells

scientific article

Efficacy of taxane regimens in patients with metastatic angiosarcoma

scientific article published on 01 July 2011

Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer

scientific article

Establishment and validation of prognostic nomograms in first-line metastatic gastric cancer patients.

scientific article

Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis

scientific article published on December 2004

FOLFOX as First-line Therapy for Gastric Cancer with Severe Peritoneal Metastasis

scientific article published in December 2017

Factors that affect the duration of the interval between the completion of palliative chemotherapy and death

scientific article published on 11 July 2009

Favorable outcome in patients with breast cancer in the presence of pathological response after neoadjuvant endocrine therapy

scientific article published on 05 April 2007

Feasibility and usefulness of the 'Distress Screening Program in Ambulatory Care' in clinical oncology practice

scientific article published on 01 July 2010

Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients

scientific article published on 05 June 2006

Genetic testing for effective Herceptin therapy

scientific article published in March 2002

Hematologic safety of breast cancer chemotherapies in patients with hepatitis B or C virus infection

scientific article

Immunohistochemical expression of HER1, HER3, and HER4 in HER2-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy

scientific article published on 01 March 2010

Immunohistochemical expression of PTEN and phosphorylated Akt are not correlated with clinical outcome in breast cancer patients treated with trastuzumab-containing neo-adjuvant chemotherapy

scientific article published on 18 November 2008

Immunohistochemical profile for unknown primary adenocarcinoma

scientific article

Influence of suboptimal treatment in patients with mediastinal primary nonseminomatous germ cell tumors

scientific article published on 25 February 2010

Leptomeningeal metastasis from ovarian carcinoma successfully treated by the intraventricular administration of methotrexate

scientific article published on 18 December 2008

Long-term outcome and pattern of relapse after neoadjuvant chemotherapy in patients with human epidermal growth factor receptor 2-positive primary breast cancer.

scientific article published on 28 May 2009

Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer

scientific article published on 05 March 2020

Morphologic Response and Tumor Shrinkage as Early Predictive Markers in Unresectable Colorectal Liver Metastases

scientific article published on 01 November 2018

Multicenter phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma

scientific article published on September 2010

Neutropenia as a Predictive Factor in Metastatic Colorectal Cancer Treated With TAS-102

scientific article published on 21 July 2016

Outpatient management of low-risk febrile patients on paclitaxel and carboplatin for ovarian cancer.

scientific article published on 20 February 2009

Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer

scientific article

Phase I Study of Alternate-Day Administration of S-1, Oral Leucovorin, and Bevacizumab for Refractory Metastatic Colorectal Cancer

scientific article published on 03 June 2020

Phase I and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer

scientific article published on 19 August 2011

Phase I and pharmacokinetic study of trabectedin, a DNA minor groove binder, administered as a 24-h continuous infusion in Japanese patients with soft tissue sarcoma

scientific article

Phase I and pharmacokinetic study of trastuzumab emtansine in Japanese patients with HER2-positive metastatic breast cancer

scientific article

Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population

scientific article published on 9 August 2007

Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy

scientific article published on 25 October 2006

Primary yolk sac tumor of the omentum: a case report and literature review

scientific article published on September 2012

Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors

scientific article published on 29 November 2008

Prognostic factors in young Japanese women with breast cancer: prognostic value of age at diagnosis

scientific article published on 14 October 2010

Questionnaire survey of treatment choice for breast cancer patients with brain metastasis in Japan: results of a nationwide survey by the task force of the Japanese Breast Cancer Society

scientific article published on 12 November 2008

Randomized phase II study of primary systemic chemotherapy and trastuzumab for operable HER2 positive breast cancer.

scientific article

Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression

scientific article published on 12 April 2014

Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group

scientific article published on 19 August 2009

Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison

scientific article published on 31 August 2016

Relapse with malignant transformation after chemotherapy for primary mediastinal seminoma: case report.

scientific article published on 24 April 2009

Safety and efficacy of a combination of docetaxel and cisplatin in patients with unknown primary cancer

scientific article published in February 2010

Salvage chemotherapy with the combination of oxaliplatin, leucovorin, and 5-fluorouracil in advanced gastric cancer refractory or intolerant to fluoropyrimidines, platinum, taxanes, and irinotecan.

scientific article published on 16 April 2018

Second platinum therapy in patients with uterine cervical cancer previously treated with platinum chemotherapy

scientific article published on 26 October 2010

Second-line chemotherapy in patients with primary unknown cancer.

scientific article published on 11 May 2011

Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer

scientific article published on 2 September 2017

Standardization of the body surface area (BSA) formula to calculate the dose of anticancer agents in Japan

scientific article

Successful Treatment of Cardiac Angiosarcoma Associated with Disseminated Intravascular Coagulation with Nab-Paclitaxel: A Case Report and Review of the Literature

scientific article published on 21 September 2017

The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with V600E mutation

The incidence and management of metachronous testicular germ cell tumors in patients with extragonadal germ cell tumors

scientific article published on 14 May 2010

The notorious "drug lag" for oncology drugs in Japan

scientific article published on February 2011

The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone.

scientific article

The use of contrast-enhanced computed tomography before neoadjuvant chemotherapy to identify patients likely to be treated safely with breast-conserving surgery

scientific article published in February 2004

Therapy-related acute promyelocytic leukemia caused by hormonal therapy and radiation in a patient with recurrent breast cancer

scientific article published on 10 July 2008

Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer

scientific article published on 12 May 2011

Tumor-marker analysis and verification of prognostic models in patients with cancer of unknown primary, receiving platinum-based combination chemotherapy

scientific article published on 22 June 2006

Unknown primary carcinoma: a feasibility assessment of combination chemotherapy with cisplatin and docetaxel

scientific article published in February 2003

Use of squamous cell carcinoma antigen as a biomarker of chemotherapy response in patients with metastatic cervical carcinoma

scientific article published on 10 August 2011

Use of the neo-adjuvant exemestane in post-menopausal estrogen receptor-positive breast cancer: a randomized phase II trial (PTEX46) to investigate the optimal duration of preoperative endocrine therapy

scientific article published on 12 April 2013

Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy

scientific article

Utility of Bayesian Single-Arm Design in New Drug Application for Rare Cancers in Japan: A Case Study of Phase 2 Trial for Sarcoma

scientific article published on 08 September 2017

Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen.

scientific article

[A feasibility study of doxorubicin/cisplatin (AP) for postoperative chemotherapy in patients with advanced endometrial cancer]

scientific article published on 01 November 2006

[Current topics of chemotherapy for sarcoma and bone neoplasms]

scientific article published on 01 March 2008

[Survey on oncologists-provided information on treatment-related infertility to breast cancer patients]

scientific article published on 01 March 2012

Paulina is supported by:

About Paulina

Help